Results 71 to 80 of about 585,688 (307)
Answered is a question asked by Daverman, Bull. Amer. Math. Soc. 84 (1978), 377-405. It is whether a 2-sphere Σ
openaire +2 more sources
Plasma membranes contain dynamic nanoscale domains that organize lipids and receptors. Because viruses operate at similar scales, this architecture shapes early infection steps, including attachment, receptor engagement, and entry. Using influenza A virus and HIV‐1 as examples, we highlight how receptor nanoclusters, multivalent glycan interactions ...
Jan Schlegel, Christian Sieben
wiley +1 more source
Fuzzy n-s-homogeneity and fuzzy weak n-s-homogeneity [PDF]
Fuzzy n-s-homogeneity and fuzzy weak n-s-homogeneity are introduced in fuzzy bitopological spaces.
Azaizeh, Almothana +3 more
core +1 more source
Homogeneity of outcome variables.
Homogeneity of outcome variables.
Jeongwoon Yang (12501365) +1 more
core +1 more source
Foram estudadas, neste trabalho, a homogeneidade e a existência de tendências na distribuição temporal da precipitação para a microrregião do Sertão do São Francisco, no estado de Alagoas.
Henderson S. Wanderley +4 more
doaj
The human gut microbiome across the life course
Despite significant individual variation and continuous change throughout life, the human gut microbiome follows some life stage‐specific trends. This article provides a brief overview of how gut microbiome composition shifts across different phases of life. Created in BioRender. Özkurt, E. (2026) https://BioRender.com/8q4nrnc.
Alise J. Ponsero +4 more
wiley +1 more source
Due to an absence of domestic certified reference materials for coal on the Polish market, an attempt was made to manufacture a new and innovative product tailored to its needs.
Więcek Katarzyna +3 more
doaj +1 more source
Homogeneity, quasi-homogeneity and differentiability of domains
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire +3 more sources
Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang +2 more
wiley +1 more source

